Heteroresistance to rifampicin

Overview of attention for article published in Indian Journal of Medical Research, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 248 followers.

Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India https://t.co/PpNYTR63Gr https://t.co/9oyLC1CLjs

Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India https://t.co/ufFrC6KiKO https://t.co/gFDj7d1KjK

Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India https://t.co/er4euQ4tad https://t.co/1ncOu1bQik

Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India https://t.co/xnSSu6Ia7L https://t.co/5iDgzdPNSc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.